NewAmsterdam Pharma (NAMS) Return on Equity [ROE] (2023 - 2026)
NewAmsterdam Pharma (NAMS) posted Return on Equity [ROE] of -40.03% for Q2 2026, down 18.72 percentage points from -21.30% a year earlier and down 8.48 percentage points from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, NewAmsterdam Pharma's Return on Equity [ROE] came in at -28.29%, up 17.91 percentage points from FY2024.
- Annual Return on Equity [ROE] has increased for three consecutive years, with a three-year change of +23.73 percentage points (FY2022 to FY2025).
- In prior years, NewAmsterdam Pharma's Return on Equity [ROE] was -46.20% in FY2024 (+3.06 pp), -49.25% in FY2023 (+2.77 pp) and -52.02% in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q4 2024.
- On a year-over-year basis, Return on Equity [ROE] increased in five of the last seven quarters, with an average year-over-year change of +14.55 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -31.55% (Q1 2026), -28.88% (Q4 2025) and -29.35% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | NewAmsterdam Pharma | 2.30 Bn | -236.30 Mn | - | -32.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -32.47% |
| Jun 30, 2026 | -40.03% |
| Mar 31, 2026 | -31.55% |
| Dec 31, 2025 | -28.88% |
| Sep 30, 2025 | -29.35% |
| Jun 30, 2025 | -21.30% |
| Mar 31, 2025 | -24.41% |
| Dec 31, 2024 | -42.52% |
| Sep 30, 2024 | -51.92% |
| Jun 30, 2024 | -57.40% |
| Mar 31, 2024 | -65.32% |
| Dec 31, 2023 | -57.06% |
API Access
NewAmsterdam Pharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();